4CPS-090 Emtricitabine/elvitegravir/cobicistat/tenofovir: effects on lipid metabolism and renal function

BACKGROUND: Emtricitabine/elvitegravir/cobicistat/tenofovir (FTC/EVG/COBI/TAF) changes levels of cholesterol and triglyceride. PURPOSE: To assess the effect on lipid metabolism and renal function in patients with human immunodeficiency virus (HIV) treated with the antiretoviral FTC/EVG/COBI/TAF. MAT...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur J Hosp Pharm
Main Authors: Navarro, M, Betancor, T, Calzado, G, Ramos, E, Gómez, E, Vera, M, Ferrer, A, Diaz, P, Suárez, M, Miguelez, M, Merino, J
格式: Artigo
語言:Inglês
出版: BMJ Group 2018
主題:
Section 4: Clinical pharmacy services
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535317/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.181
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍